West Pharmaceutical Services
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +31.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 2.6% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 43.8x | Better than 11% |
| Forward P/E | 38.8x | Better than 11% |
| Price / Sales | 8.0x | Better than 13% |
| P/E vs own 5-yr range | 55th pctl | Better than 55% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 2.1% | Better than 35% |
| Net income CAGR (3Y) | -5.5% | Better than 32% |
| Free cash flow CAGR (3Y) | 2.2% | Better than 41% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 35.9% | Better than 42% |
| Operating margin | 20.7% | Better than 78% |
| Net margin | 16.1% | Better than 73% |
| Return on equity | 16.9% | Better than 72% |
| Return on invested capital | 14.8% | Better than 82% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 10.6% | Better than 90% |
| 6-month return | 23.5% | Better than 86% |
| 12-month return (ex latest month) | 45.0% | Better than 81% |
| Distance below 52-week high | 10.9% | Better than 81% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.0x | Better than 73% |
| Debt to assets | 7.5% | Better than 74% |
| Interest coverage | 1,202.8x | Better than 99% |
| Free cash flow / net income | 95.0% | Better than 35% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 22.5% | Better than 37% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 396.69
- Open
- 387.71
- Day range
- 387.71 - 400.90
- Avg price
- 391.89
- Volume
- 623.50K
- Turnover
- 244.34M
- Turnover ratei
- 0.90%
- Volume ratioi
- 1.04
- Amplitudei
- 3.33%
- 52-week rangei
- 223.37 - 437.99
Valuation
- P/Ei
- 57.48
- P/E (TTM)i
- 43.80
- P/Bi
- 9.16
- EPSi
- 6.79
- Book value / shi
- 42.61
- Net profit
- 473.00M
- Net assets
- 2.97B
Share structure
- Market cap
- 27.19B
- Float capi
- 26.99B
- Shares out
- 69.66M
- Float sharesi
- 69.15M
Dividend & listing
- Div yield (TTM)i
- 0.23%
- Dividend (TTM)
- 0.88
- Listing date
- 1970-01-01
10.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-24.08M net over the window
Short interest
- Shares short
- 1.81M
- % of floati
- 2.59%
- Days to coveri
- 2.34
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of West Pharmaceutical Services (WST)?
West Pharmaceutical Services last traded at 390.30. This page shows a periodic quote snapshot. Check the displayed quote time.
What is West Pharmaceutical Services's market cap?
About 27.19B.
What is the P/E ratio of West Pharmaceutical Services?
The trailing twelve-month P/E is 43.80, above its own 5-year average of 42.25 — in the middle of its historical range (54.74% percentile). See the Valuation tab for the full history.
Does West Pharmaceutical Services pay a dividend?
Yes. The trailing dividend yield is 0.23%. The 2025 payout was up 4.9% from 2024. See the Dividends tab for the full payment history.
Is West Pharmaceutical Services a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 478.17, which implies 22.5% upside from the current price. This is not investment advice.
What is West Pharmaceutical Services's StockVane Quant Rating?
The StockVane Momentum strategy currently rates West Pharmaceutical Services a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
West Pharmaceutical Services discussion 0 comments